HKMA Transaction Reporting

Understand, validate and oversee HKMA reporting with confidence

Hong Kong’s OTC derivatives reporting regime is designed to improve market transparency, support supervisory oversight and strengthen control over derivatives reporting quality. Reporting is made to the Hong Kong Trade Repository (HKTR), operated by the HKMA, under the statutory reporting framework established by the HKMA and the SFC. The second phase of mandatory reporting has applied since 1 July 2017, covering OTC derivatives across the five key asset classes: interest rates, foreign exchange, equities, credit and commodities.

On 29th of September 2025, the Hong Kong regulator implemented a comprehensive overhaul of its OTC derivatives reporting regime, aligning more closely with other G20 jurisdictions through ISO 20022 XML reporting, the mandated use of Unique Transaction Identifiers (UTI) and Unique Product Identifiers (UPI), and the introduction of new Critical Data Elements (CDE) requirements.

For firms in scope, the challenge is no longer simply sending data to the repository. It is demonstrating that reportable transactions have been identified correctly, that data is complete and accurate, and that the control framework around reporting can withstand regulatory scrutiny.

What is HKMA Reporting?

HKMA reporting refers to the obligation for certain prescribed persons to report specified OTC derivative transactions to the HKTR under the Securities and Futures (OTC Derivative Transactions - Reporting and Record Keeping Obligations) Rules. The HKTR serves as Hong Kong’s trade repository and central reporting infrastructure for OTC derivatives.

The reporting framework was introduced in phases. Interim reporting began in 2013 for certain licensed banks, and the formal statutory regime expanded on 1 July 2017 to cover all five main OTC derivatives asset classes.  On 29th of September 2025 HKMA and SFC have advanced the next stage of global harmonisation by mandating the use of UTI, UPI, Critical Data Elements and the ISO 20022 standard.

Who is required to report under HKMA reporting?

Hong Kong reporting obligations apply to prescribed persons under the Reporting Rules. The HKTR and HKMA describe the in-scope population as including:

· Authorised Institutions (AIs)

· Approved Money Brokers (AMBs)

· Licensed Corporations (LCs)

· Recognised Clearing Houses (RCHs)

· ATS-CCPs licensed and regulated under the Hong Kong framework

· Furthermore, for an AI, AMB and LC, it is also required to report an OTC derivative transaction that is “conducted in Hong Kong (i.e. a Hong Kong trader)”.

The Rules also distinguish between different categories of prescribed person, including Hong Kong-incorporated authorised financial institutions, approved money brokers, licensed corporations and certain overseas-incorporated institutions, with scope and nexus tests that differ by entity type.

Scope and Hong Kong nexus

Scope under the Hong Kong regime depends not only on the product type, but also on the nature of the reporting entity and the transaction’s connection to Hong Kong. The Rules include tests based on whether the transaction is conducted in Hong Kong, whether it is booked in Hong Kong, and whether a prescribed person has conducted the transaction in Hong Kong on behalf of an affiliate.

For firms operating cross-border, that makes entity mapping, branch structure, booking model and affiliate activity especially important. In practice, firms need to be confident not just that they understand the rules in theory, but that they can apply them consistently across trading desks, booking locations and reporting workflows. This is an operational inference grounded in the structure of the Rules.

What must be reported?

Hong Kong reporting requires firms to submit prescribed data for specified OTC derivative transactions to the HKTR, together with subsequent lifecycle and update information required under the Rules and HKTR reporting manuals.  HKMA’s reporting framework requires reporting of a broad range of transaction information. The reporting guidelines list data elements including but not limited to:

• Unique Transaction Identifier (UTI)

• Unique Product Identifier (UPI)

• counterparty identity

• notional, price and other economic terms

• execution details

• valuation information

• collateral and margin data

In practice, that means firms need to control not only the core transaction record, but also the logic around identifiers, product mapping, lifecycle events and the consistency of the complete report.

Reporting deadlines

Hong Kong reporting is generally subject to a T+2 reporting timeline for reportable OTC derivative transactions under the Rules, as reflected in the HKMA / SFC reporting framework and related FAQ materials. The updated FAQs and reporting instructions remain central to interpreting detailed operational expectations.

For firms in scope, that means reporting timeliness depends on prompt identification of reportable trades, good source data quality and a process capable of identifying and correcting errors before or immediately after submission.

Is HKMA reporting single-sided, dual-sided or delegated?

Hong Kong reporting operates in practice as a dual-sided reporting framework, because each in-scope reporting entity has its own reporting obligation. Where both counterparties are separately in scope as prescribed persons, each may have its own reporting obligation depending on the legal and operational facts. The correct analysis should therefore be based on the Rules and the relevant FAQs rather than shorthand market assumptions.

Operationally, firms may use internal reporting hubs or third-party support models, but accountability for the completeness and accuracy of what is reported remains with the reporting entity. That is an operational conclusion consistent with the reporting framework and FAQ structure.

Are there HKMA reporting exemptions or reliefs?

Hong Kong’s reporting framework includes exemptions, exclusions and transitional arrangements in the Rules and FAQs, but they depend heavily on entity type, counterparty status, booking structure and transaction facts. The most reliable source for applying them in practice is the combination of the statutory Rules, the joint FAQs and the HKTR reporting manuals.

The practical point is that firms should not assume a transaction is out of scope simply because it is cross-border, booked elsewhere or handled through an affiliate structure. Relief questions need to be tested carefully against the Hong Kong framework.

Consequences of non-compliance

Hong Kong reporting failures can create regulatory, operational and reputational risk, particularly where firms cannot evidence control over scope, identifiers, lifecycle updates or data quality. The HKMA and SFC continue to update FAQs, manuals and technical specifications, which reinforces that this is an actively supervised reporting regime rather than a static compliance obligation.

For firms in scope, the expectation is clear: reporting must be accurate, timely and supported by a defensible control framework.

‍

How En:ACT helps with HKMA reporting oversight

En:ACT helps firms strengthen control over their HKMA reporting obligations by ingesting raw transaction data from any source system, performing books and records reconciliation, and assessing 100% of transactions and fields against the applicable Hong Kong reporting rules.

Using transparent, regulator-linked logic, the platform identifies:

• eligibility issues

• field-level errors

• cross-field inconsistencies

• missing or invalid identifiers

• lifecycle reporting gaps

• reporting anomalies

Each identified issue is linked directly to the specific Hong Kong reporting rule breached, giving firms a clear view of what is wrong, why it matters and where remediation is required.

En:ACT also ensures rules are kept up to date to reflect developments across:

• regulatory text

• regulator guidance

• consultation papers

• relevant industry papers

For HKMA specifically, that means firms benefit from rule coverage maintained in line with the Hong Kong Reporting Rules, HKTR reporting materials and the continuing harmonisation changes covering UTI, UPI, CDE and ISO 20022.

‍